Macquarie Group
GMED icon

Macquarie Group’s Globus Medical GMED Stock Holding History

Macquarie Group’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-619,958
Closed -$45.4M – 1689
2025
Q1 		$45.4M Sell
619,958
-52,730
-8% -$4.36M 0.06% 429
2024
Q4 		$55.6M Sell
672,688
-21,212
-3% -$1.67M 0.07% 387
2024
Q3 		$49.6M Sell
693,900
-156,803
-18% -$11.1M 0.05% 450
2024
Q2 		$58.3M Buy
850,703
+18,757
+2% +$1.12M 0.07% 378
2024
Q1 		$44.6M Buy
831,946
+40,459
+5% +$2.18M 0.05% 460
2023
Q4 		$42.2M Sell
791,487
-140,391
-15% -$6.84M 0.05% 486
2023
Q3 		$46.3M Buy
931,878
+810,568
+668% +$45.3M 0.06% 427
2023
Q2 		$7.22M Buy
+121,310
New +$6.91M 0.01% 859
2022
Q4 		– Sell
-817
Closed -$132K – 1905
2022
Q3 		$132K Sell
817
-1,393
-63% -$83.9K ﹤0.01% 1695
2022
Q2 		$124K Hold
2,210
– – ﹤0.01% 1815
2022
Q1 		$163 Hold
2,210
– – ﹤0.01% 1843
2021
Q4 		$160K Sell
2,210
-282
-11% -$20.5K ﹤0.01% 1810
2021
Q3 		$191K Hold
2,492
– – ﹤0.01% 1810
2021
Q2 		$193K Hold
2,492
– – ﹤0.01% 1808
2021
Q1 		$154K Sell
2,492
-794
-24% -$50.3K ﹤0.01% 1784
2020
Q4 		$214K Hold
3,286
– – ﹤0.01% 1642
2020
Q3 		$163K Hold
3,286
– – ﹤0.01% 1661
2020
Q2 		$157K Sell
3,286
-1,314
-29% -$63.4K ﹤0.01% 1619
2020
Q1 		$196K Hold
4,600
– – ﹤0.01% 1459
2019
Q4 		$271K Hold
4,600
– – ﹤0.01% 1519
2019
Q3 		$235K Hold
4,600
– – ﹤0.01% 1542
2019
Q2 		$195K Buy
+4,600
New +$200K ﹤0.01% 1597
2019
Q1 		– Sell
-400
Closed -$17K – 1803
2018
Q4 		$17K Buy
400
+300
+300% +$15K ﹤0.01% 1825
2018
Q3 		$6K Sell
100
-2,900
-97% -$153K ﹤0.01% 2049
2018
Q2 		$151K Sell
3,000
-2,600
-46% -$136K ﹤0.01% 1741
2018
Q1 		$279K Sell
5,600
-400
-7% -$18.8K ﹤0.01% 1590
2017
Q4 		$247K Sell
6,000
-300
-5% -$10.5K ﹤0.01% 1678
2017
Q3 		$187K Buy
+6,300
New +$192K ﹤0.01% 1771

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Macquarie Group's GMED Position: Q2 2025 in Review

Macquarie Group sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 619,958 shares — an estimated $45.4M sold.

Macquarie Group first reported a position in GMED in Q3 2017 and held it in 28 quarters. The position peaked at $58.3M in Q2 2024. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

  • Macquarie Group reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
  • Macquarie Group sold 619,958 Globus Medical shares in Q2 2025, an estimated $45.4M.
  • Macquarie Group first reported a position in Globus Medical in Q3 2017 and held it in 28 quarters.
  • Macquarie Group's Globus Medical position peaked at $58.3M in Q2 2024.
  • 480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on Macquarie Group's 13F filing for Q2 2025, filed 14 Aug 2025.